Immunome, Inc.IMNMNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P71
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-22.09%
2024-1856.21%
202370.98%
2022-58.09%
2021-43.91%
2020-29.36%
2019-28.81%
20180.00%